|
Number of oocyte retrieval cycles
|
2 (1–9)
|
2 (1–4)
|
1
|
0.210
|
|
Type of controlled ovarian stimulation, n (%)
| | | |
0.068
|
|
Short
|
49/111 (44.1)
|
4/21 (19)
|
0/3
| |
|
Long
|
26/111 (23.4)
|
11/21 (52.4)
|
1/3 (33.3)
| |
|
Ultra-long
|
16/111 (14.4)
|
2/21 (9.5)
|
1/3 (33.3)
| |
|
GnRH antagonist
|
15/111 (13.5)
|
3/21 (14.3)
|
1/3 (33.3)
| |
|
Others
|
5/111 (4.5)
|
1/21 (4.8)
|
0/3
| |
|
Total dose of gonadotropin used (IU)
|
2400 (225–6750)
|
2250 (600–2250)
|
1425 (1025–2625)
|
0.162
|
|
Number of oocytes retrieved
|
2 (0–15)
|
4 (1–11)
|
8 (8–14)
|
0.008
|
|
Fertilisation method, n (%)
| | | |
0.616
|
|
ICSI
|
35/106 (33.0)
|
6/21 (28.6)
|
2/3 (66.7)
| |
|
IVF
|
67/106 (63.2)
|
14/21 (66.7)
|
1/3 (33.3)
| |
|
Mixed
|
4/106 (3.8)
|
1/21 (4.7)
|
0/3
| |
|
Number of ET cycles
|
2 (1–8)
|
3 (2–5)
|
3 (2–4)
|
0.129
|
|
Number of ET/cycles
|
1 (1–2)
|
1 (1–2)
|
1 (1–2)
|
0.802
|
|
ET type, n (%)
| | | |
0.083
|
|
Fresh
|
49/100 (49)
|
11/27 (40.7)
|
1/9 (11.1)
| |
|
Frozen-thawed
|
51/100 (51)
|
16/27 (59.3)
|
8/9 (88.9)
| |
|
Embryo quality, (%)
| | | |
0.034
|
|
Good
|
77/100 (77)
|
16/27 (59.3)
|
9/9 (100)
| |
|
Long-term pituitary down-regulation before ET, n (%)
|
20/100 (20)
|
1/27 (3.7)
|
0/9
|
0.048
|
